Network

The research network Europe-Japan “Nanoparticles for biomedicine” is one of the Thematic Networks supported by the DAAD (German Academic Exchange Service) in its initiative “Strategic Partnerships and Thematic Networks”. The program is financed by the German Federal Ministry of Education and Research (BMBF) and was was established in 2015.

Within the network, research groups of the University of Bonn cooperate with partners in UK, Japan and Spain, to develop new magnetic nanoparticles and to test them in novel biomedical applications.

 

 

Strategy

The DFG-funded Research Unit 917 successfully investigated magnetic nanoparticles for application in gene- and cell-based therapies and set the basis for the Research Network. In 2015, the Research Network “Nanoparticles for biomedicine” was established within the DAAD “Strategic Partnerships and Thematic Networks” program to foster international collaboration of leading experts in the field of magnetic nanoparticles.

Activities

  • Regular international workshops for scientists and PhD students of the network in partner countries
  • Lab exchange / Research stays of the PhD students in the respective partner laboratories
  • Strategic meetings of the leading scientists in partner countries
  • Participation of all partners in relevant international conferences to present the research results of the network to public


Aims of the project

  • Fostering the international and research-specific cooperation between the particular partner countries
  • Establishment and extension of an attractive network for the education of young scientists (PhD students, PostDocs) in the area of nanomaterials and gene therapy
  • Regular scientific exchange of PhD students and scientists between the different areas of expertise within the network
  • Recruitment of excellent young scientists and integration into the existing network
  • Strengthen the visibility and attractiveness of the University of Bonn as an international research university

Please find more information about our aims here: Our aims